Success in preparing new vaccines for laboratories
More than 1,000 scientists gathered in Cancun, Mexico over the weekend to discuss tuberculosis prevention drugs and vaccines, which killed more than 1.8 million people in 2008, and 1 person dies every 20 seconds from this disease.
Doctor Ann Wajja, the lead researcher in Uganda, said: "Three out of eight vaccines being tested clinically, including moxifloxacin, have good results when applied to tuberculosis patients." This vaccine can shorten the duration of treatment from 6 months to 4 months and is expected to be produced within the next 5 years.
Although TB is a dangerous infectious disease, so far only one vaccine, Bacille Calmette Guerin (BCG) has been invented since 1920, but its applicability is not high. This vaccine works to prevent younger children from adults.
According to the Vaccine Study of Global Tuberculosis Prevention, 4 out of 8 vaccines being tested in clinical trials not only prevent TB infection of all ages but also prevent its effects on patients. HIV infection and drug-resistant TB patients.
- 3 common misunderstandings about vaccines
- Detecting contaminated metals and debris in a series of human vaccines
- Open the lab door for students to visit
- Preparing vaccines based on ... spider silk
- Successful development of super vaccines can protect against all types of diseases
- A breakthrough in preparing malaria vaccines
- How are Pentaxim and Quinvaxem vaccines different?
- Prepare vaccines from green plants, why not?
- The US stopped testing HIV vaccines
- Vietnam vaccines are qualified for world export
- Decode 7 misconceptions people often think about vaccines
- Things to know about 5 in 1 vaccines and 6 in 1 vaccines